InvestorsHub Logo

LittleBlondie

12/15/17 11:12 AM

#5253 RE: Door2Door #5249

this is the reason for the season

LittleBlondie

12/15/17 11:16 AM

#5255 RE: Door2Door #5249

LXGTF engages Diablo research for next step in FDA clearance..

https://finance.yahoo.com/news/lexington-biosciences-engages-clinical-research-140000876.html